Analysis of efficacy and safety in atezolizumab plus bevacizumab combination therapy for unresectable hepatocellular carcinoma 1)Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice 2)Risk factors for Early onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma

Persistent ID (NDL): info:ndljp/pid/12985690

Material type: 博士論文

Author: 安藤, 雄和

Publisher: -

Publication date: 2023-03-23

Material Format: Digital

Capacity, size, etc.: -

Name of awarding university/degree: 広島大学,博士(医学),Doctor of Philosophy in Medical Science

View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii Dissertationsから、本文を自由に閲覧できる場合があります。

Notes on use

Note (General)：: 1)Cancers 2021, 13, 3958.2)Liver Cancer 251–261.

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Search by Bookstore

Read in Disability Resources

Other Services
- テキストデータ check it on 国立国会図書館デジタルコレクション

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type: 博士論文
Title: Analysis of efficacy and safety in atezolizumab plus bevacizumab combination therapy for unresectable hepatocellular carcinoma 1)Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice 2)Risk factors for Early onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
Author/Editor: 安藤, 雄和
Author Heading: 安藤, 雄和
Publication Date: 2023-03-23
Publication Date (W3CDTF): 2023-03-23
Alternative Title: 切除不能進行肝細胞癌に対するアテゾリズマブ、ベバシズマブ併用療法の有効性と安全性の解析 1)実臨床における切除不能進行肝細胞癌患者に対するアテゾリズマブ、ベバシズマブ併用療法の早期の抗腫瘍効果および安全性 2)切除不能進行肝細胞癌患者に対するアテゾリズマブ、ベバシズマブ併用療法を受けた患者における早期の蛋白尿発症のリスク因子
Degree grantor/type: 広島大学
Date Granted: 2023-03-23
Date Granted (W3CDTF): 2023-03-23
Dissertation Number: 甲第9209号
Degree Type: 博士(医学)
Doctor of Philosophy in Medical Science
Text Language Code: eng
Alias of Author: Ando, Yuwa
Target Audience: 一般
Note (General): 1)Cancers 2021, 13, 3958.
2)Liver Cancer 251–261.
Persistent ID (NDL): info:ndljp/pid/12985690
https://dl.ndl.go.jp/pid/12985690
Collection: 障害者向け資料
Collection (Materials For Handicapped People:1): テキストデータ
Collection (particular): 国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文
https://dl.ndl.go.jp/collections/A00014
Acquisition Basis: 博士論文（自動収集）
Date Accepted (W3CDTF): 2023-09-01T22:11:33+09:00
Format (IMT): application/pdf
Access Restrictions: 国立国会図書館内限定公開
Service for the Digitized Contents Transmission Service: 図書館・個人送信対象外
Availability of remote photoduplication service: 可
Periodical Title (URI): http://ir.lib.hiroshima-u.ac.jp/00054466
Data Provider (Database): 国立国会図書館 : 国立国会図書館デジタルコレクション
https://dl.ndl.go.jp